Neuraxis, Inc.

NRXSAMEX • USD
4.72 USD
↘ 0.08 (1.67%)🟢LIVE (AS OF 02:03 PM EST)
🟢Market: OPEN

NRXS is currently priced at $4.72. Technicals currently rate "Strong Sell" while our fundamental analysis reads "Neutral". Notable factors include a concerning Altman Z-Score in the distress zone, negative Return on Equity and a bearish Death Cross on the long-term moving averages. Valuation-wise, the stock is priced at a premium — multiples like P/E and EV/EBITDA sit above sector averages.

Technical & fundamental data as of Nov 16, 2026.

Open?$4.51
High?$4.92
Low?$4.51
Prev. Close?$4.80
Volume?132.3K
Avg. Volume?163.8K
VWAP?$4.76
Rel. Volume?0.81x
Bid / Ask
Bid?$4.76 × 100
Ask?$4.77 × 100
Spread?$0.01
Midpoint?$4.77
Valuation & Ratios
Market Cap?68.1M
Shares Out?10.7M
Float?8.6M
Float %?68.8%
P/E Ratio?N/A
P/B Ratio?18.81
EPS?-$0.91
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Neuraxis Inc is a growth-stage medical technology company focused on neuromodulation therapies for chronic and debilitating conditions in the gastrointestinal (GI) digestive system, specifically from disorders of the gut-brain interaction (DGBIs) in pediatrics and adults. The company is dedicated to advancing the science with its' proprietary Percutaneous Electrical Nerve Field Stimulation (PENFS) technology. The company focuses on targeted therapies for the pediatric and adolescent population suffering from disorders of gut-brain interaction (DGBIs).
Employees
24
Market Cap
76.9M
Industry
ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS
Listed
2023-08-09
Address
11611 N. MERIDIAN ST
CARMEL, IN 46032
Phone: (812) 689-0791
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-3/3)
Medium-Term (Wave)?▼ Bearish(-2/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?
23
Z-Score?
0
Momentum?
87
Short Sent.?
64
Piotroski F-Score?3/9Weak
Altman Z-Score?-7.07Distress
Confidence?46%Low
Full Fundamental Analysis →
Short InterestElevated
Short % of Float?5.28%Elevated
Short Interest?455.9K
Days to Cover?4.4
Free Float8.6M
Avg Daily Volume104.4K
Settlement Date2026-10-30
Financial Health
Current Ratio?2.10Strong
Quick Ratio?2.01Strong
Cash Ratio?1.55Strong
Debt/Equity?0.06Low
ValuationRICHLY VALUEDvs 1 peers + S&P 500
Score
50/100
P/E?
N/A▾
P/B?
Peers
100
S&P
8
18.81HIGH▾
P/S?
Peers
100
S&P
8
10.43HIGH▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-5.3CHEAP▾
EV/Sales?
Peers
100
S&P
11
9.78HIGH▾
Returns & Efficiency
ROE?
S&P
3
-355.3%WEAK▾
ROA?
S&P
3
-193.4%WEAK▾
Cash Flow & Enterprise
FCF?$-6473968
Enterprise Value?$63.9M
Fundamentals ratios updated end of day